Cogent Biosciences, Inc.
NASDAQ:COGT
10.63 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 7.871 | 22.499 | 9.734 | 8.36 | 6.355 | 2.986 |
| Cost of Revenue
| 3.588 | 5.878 | 0.147 | 0.026 | 0.044 | 0 | 0 | 0 | 0 |
| Gross Profit
| -3.588 | -5.878 | -0.147 | 7.845 | 22.455 | 9.734 | 8.36 | 6.355 | 2.986 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0.997 | 0.998 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 170.167 | 121.627 | 55.913 | 72.648 | 43.709 | 38.285 | 29.832 | 21.992 | 6.852 |
| General & Administrative Expenses
| 34.375 | 26.212 | 19.638 | 17.422 | 10.968 | 7.454 | 4.68 | 3.433 | 2.726 |
| Selling & Marketing Expenses
| 34.341 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 34.375 | 26.212 | 19.638 | 17.422 | 10.968 | 7.454 | 4.68 | 3.433 | 2.726 |
| Other Expenses
| 0 | 3.609 | 2.811 | -0.246 | 0.078 | 0.32 | 0.274 | 0.681 | 0 |
| Operating Expenses
| 204.542 | 147.839 | 75.551 | 90.07 | 54.677 | 45.739 | 34.512 | 25.425 | 9.578 |
| Operating Income
| -208.13 | -147.839 | -75.551 | -82.199 | -32.178 | -36.005 | -26.152 | -19.07 | -6.592 |
| Operating Income Ratio
| 0 | 0 | 0 | -10.443 | -1.43 | -3.699 | -3.128 | -3.001 | -2.208 |
| Total Other Income Expenses Net
| 15.72 | 7.598 | 3.278 | 7.391 | 0.345 | 0.32 | 0.274 | 0.681 | 0 |
| Income Before Tax
| -192.41 | -140.241 | -72.273 | -74.808 | -31.833 | -34.532 | -25.492 | -18.124 | -6.592 |
| Income Before Tax Ratio
| 0 | 0 | 0 | -9.504 | -1.415 | -3.548 | -3.049 | -2.852 | -2.208 |
| Income Tax Expense
| 0 | -7.598 | -0.467 | -8.357 | -1.56 | 1.473 | -0.386 | -0.265 | 0 |
| Net Income
| -192.41 | -132.643 | -71.806 | -66.451 | -30.273 | -34.532 | -25.492 | -18.124 | -6.592 |
| Net Income Ratio
| 0 | 0 | 0 | -8.443 | -1.346 | -3.548 | -3.049 | -2.852 | -2.208 |
| EPS
| -2.42 | -2.26 | -1.85 | -6 | -3.97 | -5.55 | -3.45 | -3.1 | -1.13 |
| EPS Diluted
| -2.42 | -2.26 | -1.85 | -6 | -3.97 | -5.55 | -3.45 | -2.45 | -0.89 |
| EBITDA
| -204.542 | -147.839 | -75.404 | -89.692 | -32.178 | -34.684 | -24.981 | -18.24 | -6.413 |
| EBITDA Ratio
| 0 | 0 | 0 | -11.395 | -1.43 | -3.563 | -2.988 | -2.87 | -2.148 |